OpenAI, Creator of ChatGPT, Hits $80 Billion Valuation in Latest Deal: Report

New York: According to sources familiar with the matter, Microsoft-backed OpenAI has recently finalized a deal that values the artificial intelligence powerhouse at $80 billion or more, as reported by the New York Times.

In this transaction, OpenAI is selling existing shares in what’s termed a tender offer, spearheaded by venture firm Thrive Capital.

This arrangement allows employees to cash out their shares rather than pursuing a traditional funding round to raise capital for business operations, the report elucidates.

Despite requests for comment, OpenAI has not responded, according to a report from the global news agency Reuters.

This deal mirrors a similar agreement struck early last year, where venture capital heavyweights including Thrive Capital, Sequoia Capital, Andreessen Horowitz, and K2 Global acquired OpenAI shares in a tender offer, thereby valuing the company at approximately $29 billion.

The introduction of OpenAI’s ChatGPT in late 2022 ignited considerable interest in the realm of artificial intelligence, prompting enterprises to explore innovative applications of this transformative technology.

Furthermore, OpenAI CEO Sam Altman reportedly engages in discussions to secure funding for a chip venture. This endeavor aims to bolster the global chip manufacturing capacity, facilitating the development of cutting-edge AI tools.

Recent News

US Prosecutors to Seek Death Penalty for Luigi Mangione, Bondi Confirms

New York: U.S. Attorney General Pamela Bondi has directed federal prosecutors to pursue the death penalty against Luigi Mangione, who stands accused of fatally...

Xi Urges Stronger China-India Ties in ‘Dragon-Elephant Tango’

Beijing: Chinese President Xi Jinping has urged closer cooperation between China and India, describing their relationship as a "Dragon-Elephant tango". In a message to...

Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial)

Mumbai: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug...

Bharti AXA Life Insurance appoints Prerak Parmar as Chief Growth Officer

Kolkata: Bharti AXA Life continues to strengthen its leadership team by hiring seasoned professionals with deep domain expertise and a strong track record in driving...